ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,538Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 1456

$1.57M Total Retail Price of All Prescriptions

Rank: 27 out of 1456

544 Patients Receiving at Least One Drug in Part D
58%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 544 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

44% of this provider’s 544 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 17,936 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

56 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
HYDROCODONE-ACETAMINOPHEN 1,973 974 S3 1 6
OMEPRAZOLE 1,493 977 2 5
LEVOTHYROXINE SODIUM 975 671 3 4
SIMVASTATIN 947 553 4 2
LISINOPRIL 871 569 5 3
AMLODIPINE BESYLATE 805 594 6 1
FUROSEMIDE 747 559 7 7
CRESTOR 599 397 8 26
PRAVASTATIN SODIUM 579 386 9 9
ZOLPIDEM TARTRATE 564 274 10 14
METFORMIN HCL 556 330 11 8
POTASSIUM CHLORIDE 544 357 12 15
GABAPENTIN 528 331 13 13
NEXIUM 485 237 14 23
CITALOPRAM HBR 372 147 15 22
GLIMEPIRIDE 359 202 16 33
WARFARIN SODIUM 356 288 17 21
PROMETHAZINE HCL 353 112 R 18 77
ADVAIR DISKUS 344 188 19 63
RANITIDINE HCL 341 131 20 27
ENDOCET 327 125 S2 21 146
SPIRIVA 310 205 22 75
DIOVAN 294 230 23 35
MELOXICAM 275 128 24 30
METOPROLOL TARTRATE 273 225 25 12
AZITHROMYCIN 268 115 26 44
LOVAZA 265 135 27 162
CARVEDILOL 263 215 28 20
LANTUS 255 146 29 50
METOPROLOL SUCCINATE 246 135 30 19
TRAMADOL HCL 237 185 31 17
CLOPIDOGREL 236 171 32 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 233 124 33 24
PROAIR HFA 225 96 34 69
ROPINIROLE HCL 222 91 35 90
TAMSULOSIN HCL 217 160 36 34
ATORVASTATIN CALCIUM 212 164 37 11
LEVOFLOXACIN 210 114 38 79
FENOFIBRATE 201 52 39 56
HYDROCHLOROTHIAZIDE 201 94 39 10
CARISOPRODOL 196 0 R 41 80
SINGULAIR 195 116 42 83
MIRTAZAPINE 194 138 43 65
TRICOR 191 62 44 92
SERTRALINE HCL 184 114 45 25
NOVOLOG 184 141 45 104
PREDNISONE 179 118 47 42
ALENDRONATE SODIUM 179 153 47 36
CYMBALTA 177 98 49 52
INSULIN SYRINGE 174 109 50 64
PLAVIX 173 132 51 46
CYCLOBENZAPRINE HCL 171 37 R 52 66
AMOXICILLIN 166 84 53 112
ISOSORBIDE MONONITRATE ER 165 94 54 60
FLUTICASONE PROPIONATE 153 61 55 28
FINASTERIDE 152 145 56 110
LOSARTAN POTASSIUM 136 96 57 16
VENTOLIN HFA 126 37 58 121
PANTOPRAZOLE SODIUM 124 95 59 43
ATENOLOL 123 65 60 18
COMBIVENT 122 51 61 110
NOVOLOG FLEXPEN 122 90 61 198
ALLOPURINOL 117 51 63 31
FLUOXETINE HCL 116 35 64 55
MONTELUKAST SODIUM 114 62 65 135
POLYETHYLENE GLYCOL 3350 111 81 66 85
PEN NEEDLE 110 59 67 131
JANUVIA 109 54 68 68
FEXOFENADINE HCL 109 31 68 322
OXYCODONE HCL-ACETAMINOPHEN 108 61 S2 70 132
TERAZOSIN HCL 105 78 71 142
CLONIDINE HCL 105 68 71 39
CIPROFLOXACIN HCL 105 64 71 58
NAMENDA 104 98 74 38
PAROXETINE HCL 102 71 75 67
MORPHINE SULFATE ER 98 22 S2 76 173
ESCITALOPRAM OXALATE 97 61 77 74
CEPHALEXIN 95 43 78 123
PREMARIN 93 35 R 79 99
VENLAFAXINE HCL ER 92 55 80 89
TRAZODONE HCL 90 48 81 47
LANTUS SOLOSTAR 89 36 82 120
QUETIAPINE FUMARATE 89 35 82 78
VERAPAMIL ER 88 63 84 82
DEXILANT 86 33 85 169
OXYCODONE-ACETAMINOPHEN 85 47 S2 86 109
DIGOXIN 83 67 87 62
MEGESTROL ACETATE 80 64 R 88 179
AMITRIPTYLINE HCL 79 38 R 89 70
METOCLOPRAMIDE HCL 74 30 90 125
ZETIA 73 19 91 71
SYNTHROID 70 55 92 37
LIDODERM 69 30 93 166
MUPIROCIN 68 25 94 224
TRIAMTERENE-HCTZ 67 43 95 49
BENAZEPRIL HCL 65 30 96 57
DILTIAZEM 24HR CD 63 59 97 159
METHADONE HCL 62 0 S2 98 190
AMLODIPINE BESYLATE-BENAZEPRIL 61 38 99 61
DOXYCYCLINE HYCLATE 61 29 99 129
KLOR-CON M20 61 38 99 51
DILTIAZEM 24HR ER 61 49 99 126
DIOVAN HCT 60 45 103 59
RAMIPRIL 59 23 104 98
LIPITOR 59 35 104 76
GLYBURIDE 59 38 R 104 94
LOSARTAN-HYDROCHLOROTHIAZIDE 58 34 107 41
METFORMIN HCL ER 58 17 107 54
DONEPEZIL HCL 57 56 109 29
JANTOVEN 56 56 110 209
GEMFIBROZIL 56 34 110 117
BENICAR 56 45 110 130
DOXAZOSIN MESYLATE 54 39 113 84
HYDROXYZINE HCL 52 0 R 114 164
NASONEX 51 20 115 246
SPIRONOLACTONE 51 40 115 73
BYSTOLIC 50 46 117 102
KLOR-CON 10 50 37 117 96
MECLIZINE HCL 50 35 117 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 11, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.